SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001104659-22-037502
Filing Date
2022-03-24
Accepted
2022-03-24 16:15:30
Documents
1
Group Members
BRIAN M. ISERNSANDRA I. COUFAL, M.D.SIBLING CAPITAL FUND II-A L.P.SIBLING CAPITAL FUND II-B L.P.SIBLING CAPITAL FUND II-C L.P.SIBLING CAPITAL FUND II-D L.P.SIBLING CAPITAL VENTURES II LLCSIBLING CAPITAL VENTURES III LLCSIBLING CAPITAL VENTURES IV LLCSIBLI

Document Format Files

Seq Description Document Type Size
1 SC 13D/A tm229827d1_sc13da.htm SC 13D/A 312983
  Complete submission text file 0001104659-22-037502.txt   314927
Mailing Address 7000 SHORELINE COURT, SUITE 201 SOUTH SAN FRANCISCO CA 94080
Business Address 7000 SHORELINE COURT, SUITE 201 SOUTH SAN FRANCISCO CA 94080 415-429-7800
Tricida, Inc. (Subject) CIK: 0001595585 (see all company filings)

IRS No.: 463372526 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-90549 | Film No.: 22766653
SIC: 2834 Pharmaceutical Preparations

Mailing Address 500 YALE AVE N SEATTLE WA 98109
Business Address 500 YALE AVE N SEATTLE WA 98109 504-715-8335
Sibling Capital Ventures LLC (Filed by) CIK: 0001744971 (see all company filings)

IRS No.: 463836993 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A